Poor Performance Of New Shares In April; &Nbsp; Three Gem Shares Are Under Pressure Today.

Just in

Data show that the Japanese chemical industry focuses on the development, production and sales of PVC plastic modifier products, and is the largest manufacturer of ACR impact modifier in China.

The Japanese chemical company plans to issue 35 million new shares this year. The issue price is 22 yuan / share, corresponding to the P / E ratio of 37.29 times. The fund will be used for 25000 tons of plastic modifier, annual output of 15000 tons of plastic modifier, and other working capital projects related to the main business.

Another IPO is one of the most complete electrical inspection institutions in China.

The company plans to issue 11 million 500 thousand shares, issuing price of 76 yuan / share, corresponding to the P / E ratio of 56.43 times.

The fund will be used for the low voltage and high current switching capacity test system project, the high voltage and nuclear power plant seismic performance test system project, and the total investment is estimated to be 408 million yuan.

The last one is the production and sale of all kinds of injection equipment.

Qianshan medicine machine plans to issue 17 million shares, issuing price of 29.30 yuan / share, corresponding to the P / E ratio of 45.78 times, the fund-raising fund is mainly used to expand the new product plastic ampoule injection production automatic line and automatic intelligent light inspection machine capacity.

According to the statistics of reporters, a total of 24 new shares landed on A shares in April, of which 16 new shares were listed on the first day, and the breaking rate reached an astonishing 67% on the first day of the month.

Insiders pointed out that in the context of this new share becoming a "outcast" market, it has become a top priority to choose the best purchase.

From the recent performance of IPO, companies with lower selling price and smaller market value tend to receive more market attention.

In combination with other factors, market participants suggest that investors should give priority to purchase Qianshan medicine machine.